MedPath

Evaluation of the Glycemic Index in 4 Dairy Beverages.

Not Applicable
Completed
Conditions
Cognitive Performance
Glycemic Index
Interventions
Other: Experimental product
Other: Control product
Registration Number
NCT05204823
Lead Sponsor
Universidad Católica San Antonio de Murcia
Brief Summary

The objective of the study is to evaluate the glycemic index and glycemic load of 4 chocolate milk drinks.

Detailed Description

Subjects will make a total of 5 visits. Four visits where they will drink a chocolate milkshake at each visit. In the other visit they will take glucose, as a comparator product.

Due to the low amount of sugars in the shakes, subjects will drink the equivalent of 25g of glucose.

At each visit subjects will have to come fasting, and samples will be collected at 9 different times.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Subjects of both sexes (10 men and 10 women).
  • Subjects aged between 20 and 35 years.
  • Subjects with a body mass index between 20 and 25 kg/m2.
Exclusion Criteria
  • Subjects suffering from diabetes mellitus or any chronic disease.
  • Subjects with medical problems or a diagnosed psychiatric disorder.
  • Subjects with alcohol abuse or excessive alcohol consumption (>3 glasses of wine or beer/day).
  • Subjects consuming any pharmacological medication that may affect memory.
  • Participation in another clinical trial in the three months prior to the study.
  • Unwillingness or inability to comply with clinical trial procedures.
  • Subjects whose condition does not make them eligible for the study according to the investigator's criteria.
  • Pregnant or lactating women.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Experimental Product 2Experimental productConsumption of 282.81 ml of product 1 (corresponding to 25g of glucose). Subjects will take this amount only on the day of the visit that they are to consume this product.
Control productControl productConsumption of 25g of glucose. Subjects will take this amount only on the day of the visit that they are to consume this product.
Experimental Product 4Experimental productConsumption of 573,39 ml of product 1 (corresponding to 25g of glucose). Subjects will take this amount only on the day of the visit that they are to consume this product.
Experimental Product 1Experimental productConsumption of 221.24 ml of product 1 (corresponding to 25g of glucose). Subjects will take this amount only on the day of the visit that they are to consume this product.
Experimental Product 3Experimental productConsumption of 589,62 ml of product 1 (corresponding to 25g of glucose). Subjects will take this amount only on the day of the visit that they are to consume this product.
Primary Outcome Measures
NameTimeMethod
GlucoseThe glucose evolution will be measured for 210 minutes after product consumption.

It will be evaluated by means of a glucometer.

Secondary Outcome Measures
NameTimeMethod
GlucoseEach product will be measured at 15, 30, 45, 60, 90, 120 and 150 minutes after consumption.

It will be evaluated by means of a glucometer.

Trial Locations

Locations (1)

Catholic University of Murcia

🇪🇸

Murcia, Spain

© Copyright 2025. All Rights Reserved by MedPath